CTS at a glance
CTS CORP (CTS, SEC CIK 26058) filed its latest 10-K annual report on February 24, 2026, a 10-Q quarterly report on July 28, 2026, an 8-K current report on July 28, 2026 and Form 4 insider filings as recently as July 30, 2026. SignalX summarizes each filing with AI and tracks the company's insider trades and institutional holders.
- For the fiscal year ended December 31, 2025 (FY2025), CTS CORP (CTS) reported revenue of $541.3 million (up 5.0% from FY2024) and net income of $65.3 million. Diluted EPS was $2.19.
- As of June 30, 2026, 31 institutional investment managers tracked by SignalX reported holding CTS CORP (CTS) shares worth $821.1 million in 13F-HR filings.
Source: SEC EDGAR (XBRL financial data, 13F-HR and Form 4 filings).
- Revenue · FY2025
- $541.3M
- +5.0% vs prior year
- Insiders · 90 days
- 0 buys · 0 sells
- No open-market trades
- 13F holders
- 31 funds
- $821.1M · +0 vs prior quarter
- Latest 8-K
- Jul 28, 2026
- Item 7.01
AI 10-K Annual Report Analysis
Latest 10-K, fiscal year ended Dec 31, 2025
Business Overview
- Core business model information not detailed; filing focuses on equity compensation and governance
- Equity compensation plans include 786,209 securities outstanding with $36.48 weighted-average exercise price
- 1,017,684 shares available for future issuance under approved equity plans as of December 31, 2025
- Deferred stock accounts hold 4,722 CTS common stock units for non-employee directors, plan amended in 2004
- No new products, segments, or strategic shifts disclosed in business section this year
Risk Factors
- Acquisition of SyQwest for $121.9M on July 29, 2024, funded by cash and borrowings under prior revolving credit facility
- Exposure to cyclicality in transportation market; warranty reserves 0.3%-0.4% of net sales, impacting product quality liability estimates
- Operating lease obligations $25.3M with $3.45M due within 12 months for land, buildings, equipment critical to operations
- Goodwill impairment testing relies on market capitalization and discount rates; risk of impairment if market cap declines significantly
- Long-term debt $57.5M principal under Revolving Credit Facility with $12.0M interest payments through maturity, interest rate swaps hedge $50M through Dec 2026
Management Discussion & Analysis
- Revenue $541.3M, up 5.2% YoY ($26.6M increase) driven by aerospace, defense, medical markets, SyQwest acquisition adding $22.3M
- Gross margin 38.4% vs 36.4%, operating margin 15.3% vs 13.8%, net earnings $65.3M up 17.7%, diluted EPS $2.19 vs $1.81
- Best segment: diversified end markets up $43.0M or 16.3%; worst segment: transportation down $16.4M or 6.6%
- Operating cash flow $102.1M; capital expenditures $15.7M; treasury stock repurchases $56.2M; dividends $4.8M; debt reduced by $34.8M
- New $300M revolving credit facility secured, matures 2030, management expects adequate liquidity; risk includes market softness and EPA settlement charge
AI summary of the CTS 10-K filed . Generated from the filing text; verify against the original.View on SEC EDGARHow to read a 10-K
AI 10-Q Quarterly Report Analysis
Latest 10-Q, quarter ended Jun 30, 2026
Risk Factors
- No new or changed risk factors from the December 31, 2025 Form 10-K
- Carried-forward risks unchanged; filing provides no quarter-specific regulatory or legal updates
- Share repurchase authorization up to $100 million, with $78,265,872 remaining as of June 30, 2026
- 63,530 shares repurchased during the quarter at average prices of $52.51 and $58.69
AI summary of the CTS 10-Q filed . Generated from the filing text; verify against the original.View on SEC EDGAR10-K vs 10-Q vs 8-K
AI 8-K Current Report Analysis
The most recent material events, by 8-K item
Item 7.01: Regulation FD Disclosure
- Investor presentation may guide CTS meetings with investors and analysts during fiscal year ended December 31, 2026
- Exhibit 99.1 contains the presentation and may be presented in modified or partial form
Item EX-99.1: Item EX-99.1
- FY2026 revenue guidance $565–$585M and adjusted diluted EPS $2.55–$2.70
- LTM revenue $564.3M, up from $541.3M, with adjusted EBITDA margin 24.0%
Item 7.01: Regulation FD Disclosure
- CTS webcast scheduled July 28, 2026, covering second-quarter results ended June 30, 2026
- Investor presentation slides furnished as Exhibit 99.2 for earnings-call review
Item 2.02: Results of Operations and Financial Condition
- Q2 2026 results for quarter ended June 30, 2026, released July 28, 2026
- Detailed financial results contained in Exhibit 99.1
Item EX-99.1: Item EX-99.1
- Q2 sales $144.8M, up 7% YoY; diversified markets rose 15% and reached 59% of revenue
- Adjusted gross margin 41.5% vs 38.7%; adjusted EBITDA margin 25.4% vs 23.0%
Item 5.02: Departure/Appointment of Directors or Principal Officers
- CEO succession effective July 6, 2026: Pratik Trivedi replaces Kieran O’Sullivan, who becomes Executive Chairman
- Trivedi’s appointment adds a ninth director, expanding the Board from eight members
AI summaries of CTS 8-K current reports filed with the SEC. What 8-K item codes mean
SignalX for CTS
Don't miss the next CTS filing
- Alerts as it files. A push when CTS files an 8-K or an insider trades.
- Fund moves. Which tracked funds opened, added or cut CTS, by share count.
- Ask anything. An AI agent that reads every CTS filing and answers with sources.
Recent Insider Transactions (Form 4)
Latest reported trades by officers, directors and 10% owners
| Insider | Type | Date | Shares | Price |
|---|---|---|---|---|
| Pacioni Mark R. | F | Jul 29, 2026 | 531 | $61.53 |
| Trivedi Pratik | A | Jul 6, 2026 | 14,253 | $60.34 |
| Trivedi Pratik | F | May 8, 2026 | 314 | $61.75 |
| Trivedi Pratik | F | May 8, 2026 | 1,742 | $61.75 |
| O'SULLIVAN KIERAN M | A | Feb 24, 2026 | 16,873 | $52.94 |
| Agrawal Ashish | F | Feb 24, 2026 | 2,024 | $52.94 |
| Agrawal Ashish | A | Feb 24, 2026 | 4,310 | $52.94 |
| O'SULLIVAN KIERAN M | F | Feb 24, 2026 | 7,526 | $52.94 |
Financial SummaryXBRL
| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Profitability | |||
| Revenue | - | $515.8M | $541.3M |
| Gross Profit | $190.9M | $189.2M | $208.0M |
| Operating Income | - | $72.8M | $82.6M |
| Net Income | $60.5M | $58.1M | $65.3M |
| Gross Margin | - | 36.7% | 38.4% |
| Op. Margin | - | 14.1% | 15.3% |
| Net Margin | - | 11.3% | 12.1% |
| Balance Sheet | |||
| Total Assets | $741.2M | $766.1M | $764.3M |
| Equity | - | $530.9M | $551.8M |
| ROE | - | 10.9% | 11.8% |
| Per Share | |||
| EPS | $1.92 | $1.89 | $2.19 |
| Cash Flow | |||
| Operating CF | - | $99.3M | $102.1M |
Source: XBRL data in CTS CORP (CTS)'s 10-K filings on SEC EDGAR, in USD. Compare across companies →
13F Fund Holdings: Quarterly Trend
Latest: Q2 2026Aggregate CTS share value held by 13F filers tracked by SignalX, by quarter.
Quarterly totals table
| Quarter | Funds | Total value |
|---|---|---|
| Q2 2026 | 31 | $821.1M |
| Q1 2026 | 31 | $584.0M |
| Q4 2025 | 29 | $528.9M |
| Q3 2025 | 30 | $508.4M |
| Q2 2025 | 27 | $535.4M |
| Q1 2025 | 24 | $323.7M |
| Q4 2024 | 21 | $370.0M |
| Q3 2024 | 18 | $191.1M |
- T. Rowe Price Group+170.4K (+405%)
- Two Sigma Investments+120.9K (+64%)
- BlackRock+97.3K (+2%)
- Millennium Management+60.6K (+116%)
- Vanguard Portfolio Management LLC+48.1K (+4%)
- Renaissance Technologies LLC−77.0K (-20%)
- Bank of America Corp−66.3K (-31%)
- Dimensional Fund Advisors−36.2K (-3%)
- Goldman Sachs Group−29.8K (-19%)
- Raymond James Financial−24.5K (-11%)
Source: 13F-HR filings on SEC EDGAR (aggregated from 211 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe. How 13F filings work
CTS filing archive
AI analysis pages for each 10-K, 10-Q and 8-K
10-K annual reports
10-Q quarterly reports
Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4
| Form | Filing date | Period | Analysis | SEC |
|---|---|---|---|---|
| 4 | Jul 30, 2026 | - | - | - |
| 8-K | Jul 28, 2026 | - | Analysis | - |
| 8-K | Jul 28, 2026 | - | Analysis | - |
| 10-Q | Jul 28, 2026 | Jun 30, 2026 | Analysis | |
| 4 | Jul 7, 2026 | - | - | - |
| 8-K | Jun 25, 2026 | - | Analysis | - |
| 8-K | May 19, 2026 | - | Analysis | |
| 4 | May 12, 2026 | - | - | |
| 8-K | Apr 29, 2026 | - | Analysis | - |
| 8-K | Apr 29, 2026 | - | Analysis | - |
| 10-Q | Apr 29, 2026 | Mar 31, 2026 | Analysis | |
| SC 13G | Apr 29, 2026 | - | - | |
| 4 | Feb 26, 2026 | - | - | - |
| 4 | Feb 26, 2026 | - | - | - |
| 10-K | Feb 24, 2026 | Dec 31, 2025 | Analysis | |
| 4 | Feb 13, 2026 | - | - | |
| 4 | Feb 13, 2026 | - | - | |
| 4 | Feb 13, 2026 | - | - | |
| 4 | Feb 13, 2026 | - | - | |
| 4 | Feb 11, 2026 | - | - | |
| 4 | Feb 11, 2026 | - | - | |
| 4 | Feb 11, 2026 | - | - | |
| 8-K | Feb 10, 2026 | - | - | |
| 8-K | Feb 10, 2026 | - | - | |
| 4 | Feb 9, 2026 | - | - |
Related Information Technology companies
- BHE · BENCHMARK ELECTRONICS INCPrinted Circuit Boards
- CLS · Celestica IncPrinted Circuit Boards
- FLEX · Flex LtdPrinted Circuit Boards
- JBL · JabilPrinted Circuit Boards
- KE · Kimball Electronics, Inc.Printed Circuit Boards
- PLXS · PLEXUS CORPPrinted Circuit Boards
- SANM · SANMINA CORPPrinted Circuit Boards
- TTMI · TTM TECHNOLOGIES INCPrinted Circuit Boards
CTS SEC filings: frequently asked questions
Which institutions hold CTS stock?
As of June 30, 2026, the largest CTS CORP (CTS) holders among the 13F filers tracked by SignalX were BlackRock ($293.5 million), Vanguard Portfolio Management LLC ($82.2 million), Vanguard Capital Management LLC ($79.4 million), Dimensional Fund Advisors ($77.8 million), State Street Corp ($76.8 million). 13F-HR reports are filed up to 45 days after each quarter ends.
What was CTS's revenue in fiscal year 2025?
For the fiscal year ended December 31, 2025 (FY2025), CTS CORP (CTS) reported revenue of $541.3 million (up 5.0% from FY2024) and net income of $65.3 million. Diluted EPS was $2.19. The figures come from the XBRL data in the 10-K.
What are the main risks in CTS's latest 10-K?
In the 10-K filed February 24, 2026, CTS CORP (CTS) flagged: Acquisition of SyQwest for $121.9M on July 29, 2024, funded by cash and borrowings under prior revolving credit facility. Exposure to cyclicality in transportation market; warranty reserves 0.3%-0.4% of net sales, impacting product quality liability estimates. (AI summary of the Risk Factors section.)
What did CTS report in its latest 8-K?
CTS CORP (CTS) filed an 8-K on July 28, 2026 reporting Item 7.01 (Regulation FD Disclosure). Investor presentation may guide CTS meetings with investors and analysts during fiscal year ended December 31, 2026.
What are the latest CTS SEC filings?
CTS CORP (CTS) filed its latest 10-K annual report on February 24, 2026, a 10-Q quarterly report on July 28, 2026, an 8-K current report on July 28, 2026 and a Form 4 insider filing on July 30, 2026.
What is CTS's SEC CIK number?
CTS CORP (CTS)'s SEC Central Index Key (CIK) is 26058. EDGAR lists every CTS filing under that number.
Ask anything about CTS
The research agent reads CTS's filings, financials, insider trades and 13F holders, then answers with sources.